Abstract
The colligative concept of seronegative spondarthritis was introduced by Moll, Haslock, Macrae and Wright in 1974 (Table 12.1). At that time it was suggested that this concept would have aetiological, diagnostic and therapeutic importance, and each of these predictions has been born out in the subsequent decade.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ansell, B. M., Major, G., Lyanage, S. P., Gumpel, J. M., Seifert, M. H., Mathews, J. A. and Engler, C. (1978) A comparative study of Butacote and Naprosyn in ankylosing spondylitis. Ann. Rheum. Dis., 37, 436–9.
Bird, H. A. and Dixon, A. St. J. (1977) Failure of D-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA B27-associated arthropathy. Ann. Rheum. Dis., 36, 289.
Black, R. L., O’Brien, W. M., Van Scott, E. J. (1964) Methotrexate therapy in psoriatic arthritis — double-blind study on 21 patients. J. Am. Med. Assoc., 189, 743–7.
Bowman, C., Dieppe, P. and Settas, L. (1983) Remission of pseudospondylitis with treatment of Whipple’s disease. Br. J. Rheumatol., 22, 181–2.
Calcraft, B., Tildesley, G., Evans, K. T., Gravelle, H., Hole, D. and Lloyd, K. N. (1974) Azapropazone in the treatment of ankylosing spondylitis: a controlled clinical trial. Rheumatol. Rehabil., 13, 23–9.
Calin, A. and Fries, J. F. (1975) Striking prevalence of ankylosing spondylitis in ‘healthy’ W27 positive males and females. N. Engl. J. Med., 293, 835–9.
Chalmers, A., Kapgrove, R. E., Reynolds, W. J. and Urowitz, M. B. (1978) Postdiarrhoeal arthropathy of Yersinia pseudotuberculosis. Can. Med. Assoc. J., 118, 515–16.
Christiansen, F. T., Hawkins, B. R., Dawkins, R. L., Owen, E. T. and Potter, R. M. (1979) The prevalence of ankylosing spondylitis among B27 positive normal individuals — a reassessment. J. Rheumatol., 6, 713–18.
Cohen, L. M., Mittal, K. K., Schmid, F. R., Rogers, L. F. and Cohen, K. L. (1976) Increased risk for spondylitis stigmata in apparently healthy HLA W27 men. Ann. Intern. Med., 84, 1–4.
Court Brown, W. M. and Doll, R. (1965) Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br. Med. J., 2, 1327.
Cuthbert, M. F. (1974) Adverse reactions to non-steroidal antirheumatic drugs. Curr. Med. Res. Opinion, 2, 600–10.
Day, T. K. (1983) Intestinal perforation associated with osmotic slow-release indomethacin capsules. Br. Med. J., 287, 1671–2.
Dorwart, B. B., Gall, E. P., Schumacher, H. R. and Krauser, R. E. (1978) Chrysotherapy in psoriatic arthritis. Arthr. Rheum., 21, 513–15.
Editorial (1976) Anti-rheumatic drugs; plenty is not enough. Br. Med. J., 1, 59–60.
Feldges, D. H. and Barnes, C. G. (1974) Treatment of psoriatic arthropathy with either azathioprine or methotrexate. Rheumatol. Rehabil., 13, 120–4.
Gibson, T. and Laurent, R. (1980) Sulindac and indomethacin in the treatment of ankylosing spondylitis: a double-blind cross-over study. Rheumatol. Rehabil., 19, 189–92.
Godfrey, R., Gum, O. B., and Maltz, B. A. (1977) Evaluation of fenoprofen calcium (Nalfon) in ankylosing spondylitis. Abstr. XIV Int. Congr. Rheumatol, San Francisco, 168.
Golding, D. N. (1974) D-penicillamine in ankylosing spondylitis and polymyositis. Postgr. Med. J., Suppl., pp. 62–5.
Hill, H. F. H. and Hill, A. G. S. (1973) Naprosyn in ankylosing spondylitis. in Naprosyn in the Treatment of Rheumatic Diseases (ed. G. A. Christie), Syntex Pharmaceuticals, Maidenhead, pp. 42–6.
Hopkins, R., Bird, H. A., Jones, H., Hill, J., Surrall, K. E., Astbury, C., Miller, A. and Wright, V. (1985) A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis. Ann. Rheum. Dis., 44, 189–93.
Huskisson, E. C., Taylor, R. T., Burston, D., Chuter, P. J. and Hart, F. D. (1970) Evening indomethacin in the treatment of rheumatoid arthritis. Ann. Rheum. Dis., 29, 3 93–6.
Huskisson, E. C., Woolf, D. L., Balme, H. W., Scott, J. and Franklyn, S. (1976) Four new anti-inflammatory drugs: responses and variations. Br. Med. J., 1, 1048–9.
Jessop, J. D. (1976) Double-blind study of ketoprofen and phenylbutazone in ankylosing spondylitis. Rheumatol. Rehabil. Suppl., 37–42.
Juvakoski, T. and Lassus, A. (1982) A double-blind evaluation of ketoprofen and indomethacin in Reiter’s disease. Scand. J. Rheumatol., 11, 106–8.
Kapgrove, R. E., Little, A. H., Graham, D. C. and Rosen, P. S. (1980) Ankylosing spondylitis: survival in men with and without radiotherapy. Arthr. Rheum., 23, 57–61.
Kersley, G. D. (1968) Amethopterin (methotrexate) in connective tissue disease — psoriasis and polyarthritis. Ann. Rheum. Dis., 27, 64–6.
Lassus, A. (1976) A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter’s disease. Curr. Med. Res. Opinion, 4, 65–9.
Leatham, P. A., Bird, H. A., Wright, V. and Fowler, P. D. (1982) The run-in period in trial design: a comparison of two non-steroidal anti-inflammatory agents in psoriatic arthropathy. Agents Actions, 12, 221–4.
Leirisalo, M., Skylv, G., Kousa, M., Voipio-Pulkki, L-M., Suoranta, H., Nissila, M., Hvidman, L., Nielsen, E. D., Svejgaard, A., Tillikainen, A. and Laitinen, O. (1982) Follow-up study on patients with Reiter’s disease and reactive arthritis with special reference to HLA B27. Arthr. Rheum., 25, 249–59.
Lorig, K., Lubeck, D., Kraines, R. G., Seleznick, M. and Holman, H. R. (1985) Outcomes of self-help education for patients with arthritis. Arthr. Rheum., 28, 680–5.
McAdam, L. P., O’Hanlan, M. A. and Willkens, R. F. (1981) Piroxicam in ankylosing spondylitis: a 14-week controlled double-blind study comparing piroxicam to phenylbutazone, in Proc. 1 5th Int. Congr. Rheumatol., Paris, France. Pub. Academy Professional Information Services, Maddison Avenue, New York, USA, pp. 87–94.
Mielants, H. and Veys, E. M. (1985) Sulphasalazine (Salazopyrin) in HLA—B27 related reactive arthritis. Abstracts of the XVIth International Congress of Rheumatology, Sydney, f. 107.
Mitchell, E. P. and Schein, P. S. (1982) Gastrointestinal toxicity of chemotherapeutic agents. Seminars Oncol., 9, 52–64.
Moll, J. M. H., Haslock, I., Macrae, I. F. and Wright, V. (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies and BehÇet’s syndrome. Medicine (Baltimore), 53, 343–64.
Mullins, J. F., Maberry, J. D. and Stone, O. J. (1966) Reiter’s syndrome treated with folic acid antagonists. Arch. Dermatol., 94, 335.
Nahir, A. M. and Scharf, Y. (1980) A comparative study of diclofenac and sulindac in ankylosing spondylitis. Rheumatol. Rehabil., 19, 193–8.
Nikolic, J. and Lukacevic, D. (1975) Ibuprofen (‘Bruf en’) in the treatment of ankylosing spondylitis. Curr. Med. Res. Opinion, 3, 573–5.
Noer, H. R. (1966) An ‘experimental’ epidemic of Reiter’s syndrome. J. Am. Med. Assoc., 197, 693–7.
Owen, E. T. and Cohen, M. L. (1979) Methotrexate in Reiter’s disease. Ann. Rheum. Dis., 38, 48–50.
Peter, E. and Veress, M. (1975) Comparison of the action of naproxen and indomethacin in the double-blind test on post-midnight pain in patients with ankylosing spondylitis. Arzneimittelforsch, 25, 324–5.
Rampton, D. S. and Slader, G. E. (1981) Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad. Med. J., 57, 297–9.
Rheinberger, K. (1976) Efficacy and tolerance of Voltaren and indomethacin in patients with ankylosing spondylitis. Therapiewoche, 26, 2916–19.
Richter, M. B., Kinsella, P. and Corbett, M. (1980) Gold in psoriatic arthropathy. Ann. Rheum. Dis., 39, 279–80.
Roberts, M. E. T., Wright, V., Hill, A. G. S. and Mehra, A. C. (1976) Psoriatic arthritis: follow-up study. Ann. Rheum. Dis., 35, 206–12.
Rubenstein, H., Klamut, M., Adams, E. and Sundstrom, W. (1985) Liver biopsy in patients with rheumatoid arthritis receiving methotrexate. Abstracts of the XVIth International Congress of Rheumatology, Sydney, p. 128.
Sharon, P., Ligumsky, M., Rachmilewitz, D. and Zor, U. (1978) Role of prostaglandins in ulcerative colitis: enhanced production during active disease and inhibition by sulphasalazine. Gastroenterology, 75, 63 8–40.
Shipley, M., Berry, H. and Bloom, B. (1980) A double-blind cross-over trial of indomethacin, fenoprof en and placebo in ankylosing spondylitis, with comments on patient assessment. Rheumatol. Rehabil., 19, 122–5.
Simpson, M. R., Simpson, N. R. W., Scott, B. O. and Beatty, D. C. (1966) A controlled study of flufenamic acid in ankylosing spondylitis. Ann. Phys. Med. (Suppl.), 126– 8.
Stevens, M., Morrison, M. and Sturrock, R. D. (1985) Penicillamine in ankylosing spondylitis: a double-blind placebo-controlled trial. J. Rheumatol., 12, 735–7.
Sturrock, R. D. and Hart, F. D. (1974) Double-blind cross-over comparison of indomethacin, flurbiprofen and placebo in ankylosing spondylitis. Ann. Rheum. Dis., 33, 129–31.
Sydnes, O. A. (1981) Comparison of piroxicam and indomethacin in ankylosing spondylitis: a double-blind cross-over trial. Br. J. Clin. Pract., 35, 40–4.
Van Gerwen, F., Van der Korst, J. K. and Gribnau, F. W. J. (1978) Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis. Ann. Rheum. Dis., 37, 85–8.
Wasner, C., Britton, M. C., Kraines, G., Kaye, R. L., Bobrove, A. M. and Fries, J. F. (1981) Non-steroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. J. Am. Med. Assoc., 246, 2168–72.
Weinstein, G. D. and Frost, P. (1971) Methotrexate for psoriasis. A new therapeutic schedule. Arch. Dermatol., 103, 33–8.
Williams, H. J., Willkens, R. F., Samuelson, C. O., Alarcón, G. S., Guttadavria, M., Yarboro, C., Polisson, R. P., Weiner, S. R., Luggen, M. E., Billingsley, L. M., Dahl, S. L., Egger, M. J., Reading, J. C. and Ward, J. R. (1985) Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthr. Rheum., 28, 721–30.
Willkens, Clegg, Ward, Marks, Greene, Tolan and Roth (1985) Liver biopsies in patients on low dose pulse methotrexate (MTX) for the treatment of R.A. Abstracts of the XVIth International Congress of Rheumatology, Sydney. f. 15. (NB: No initials quoted in abstract.)
Zachariae, E., Kragballe, K. and Zachariae, H. (1985) Methotrexate in psoriatic arthritis. Abstracts of the XVIth International Congress of Rheumatology, Sydney, p. 131.
Zachariae, H., Søgaard, H. and Zachariae, E. (1985) Methotrexate toxicity in psoriasis and psoriatic arthritis. Abstracts of the XVIth International Congress of Rheumatology, Sydney, p. 132.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 J. M. H. Moll, H. A. Bird and A. Rushton
About this chapter
Cite this chapter
Haslock, I. (1986). The spondarthritides. In: Moll, J.M.H., Bird, H.A., Rushton, A. (eds) Therapeutics in Rheumatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2883-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2883-2_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-24540-4
Online ISBN: 978-1-4899-2883-2
eBook Packages: Springer Book Archive